Aug 20, 2024, 16:41
Elvina Almuradova: Metastasis-free or treatment-free survival
Elvina Almuradova, Medical Oncologist Ambassador at European School of Oncology, shared a post on X about a recent paper titled “Metastasis-Free Survival Versus Treatment-Free Survival in Biochemically Recurrent Prostate Cancer: The EMBARK Trial” published in Journal of Clinical Oncology.
Authors: David J. Einstein, Meredith M. Regan, Julia S. Stevens, David F. McDermott and Ravi A. Madan.
“Metastasis-free or treatment-free survival?
The EMBARK trial raises tough questions for prostate cancer care.
Which would you choose?
Is the trade-off worth it?”
Source: Elvina Almuradova/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 22:40
Dec 21, 2024, 22:37
Dec 21, 2024, 22:26
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19